Autres langues Alkermes plc

Actions

ALKS

IE00B56GVS15

Temps réel estimé Cboe BZX Autres places de cotation 19:02:30 06/05/2024			Varia. 5j.	Varia. 1 janv.
23,88 ^USD	-0,69%		-3,78%	-13,70%

02/05	ALKERMES PLC : UBS déconseille le dossier	ZM
01/05	Alkermes : des bénéfices et des revenus en hausse au 1er trimestre, mais qui ne sont pas à la hauteur des attentes des investisseurs	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk	02/05
Alkermes : Q1 2024 Earnings Call Script FINAL 5 1 2024	02/05
Alkermes : ALKS Q1 2024 Earnings Slides FINAL 5 1 2024	02/05
Alkermes's Q1 Earnings, Revenue Grow But Miss Street View	01/05
Alkermes: Q1 Earnings Snapshot	01/05
Earnings Flash (ALKS) ALKERMES Reports Q1 Revenue $350.4M, vs. Street Est of $360.3M	01/05
Earnings Flash (ALKS) ALKERMES Posts Q1 EPS $0.43, vs. Street Est of $0.58	01/05
Alkermes plc Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
Alkermes plc Reports First Quarter 2024 Financial Results	01/05
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1	24/04
Alkermes to Report First Quarter Financial Results on May 1, 2024	17/04
Alkermes Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia	10/04
BlackBerry, Alkermes rise; Neogen, Tilray Brands fall, Tuesday, 4/9/2024	09/04
Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday	09/04
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study	09/04
Alkermes plc Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia	09/04
Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing	19/03
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	07/03
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	07/03
European Equities Traded in the US as American Depositary Receipts Advance Wednesday	06/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Alkermes plc

Actions

ALKS

IE00B56GVS15

Autres langues

Filtres